• Company Profile / Strategy
• Board of Directors

Company Profile / Strategy

Profile

Jourdan plc was formed in 1926, and is a holding company with interests in both the consumer and industrial markets. Its principal subsidiaries are:

• Westfield Medical Limited - acquired in 2000, the company has been dedicated to the manufacture of single use sterilisation packaging since its creation over 40 years ago. Westfield Medical is now the sole UK manufacturer of a full and comprehensive range of sterilisation products for use in hospital sterile service departments.
• Clinipak Limited - acquired by Westfield Medical Limited in 2006. Clinipak is a specialist manufacturer and distributor of single use sterilisation products that complements the Westfield range. In addition it has some unique solutions for the reduction of both pack damage and condensation issues with choice dry wraps, tray liners and pack protection products.
• Nelsons Labels (Manchester) Limited - established in 1919, and acquired by Jourdan in 2000. Nelson's Labels is the UK’s, and increasingly Europe’s, premier supplier of specialist labels to the bedding, upholstery and carpet industries. Its reputation is built on its commitment to providing only the highest levels of quality and service.

Strategy

The Company's strategy is to create a diversified group of companies comprising niche businesses focussed on maximising shareholder returns. A key aspect of this involves the purchase of small, sometimes publicly quoted, companies in which the Directors see potential for growth.

By managing niche businesses within a single group, the Directors aim to:

• improve operational efficiencies and provide additional financial support where necessary;
• increase the size and diversification of the Group;
• reduce the risk associated with exposure to single operation.

The Board intends to continue to achieve these objectives in the following ways:

• by acquiring small companies with strong market positions, where lack of size or inclination to build their operations limits the prospects of future shareholder returns;
• by improving operations through the application of proven management skills and the provision of resources for future bolt-on opportunities;
• by using Group resources to build up critical mass in chosen niche sectors; and
• by enhancing shareholder returns and liquidity through the optimum financing of acquisitions.